Investor directory

Hayfin Capital Management

Hayfin Capital Management, established in 2009, is a London-based independent investment firm specializing in private credit and alternative asset management. The company offers tailored lending solutions to middle-market European companies and provides asset management services to institutional clients. Hayfin operates across Europe and the United States, with offices in London, Paris, Madrid, Frankfurt, Luxembourg, Tel Aviv, and New York. The firm employs a value-investing approach, focusing on four strategies: Direct Lending, Special Opportunities, High-Yield Credit, and Securitized Credit. Hayfin's team comprises industry generalists with expertise in managing complex restructurings, along with dedicated specialists in healthcare, shipping, and real estate.
http://hayfin.com
https://crunchbase.com/organization/hayfin-capital-management
https://linkedin.com/company/hayfin
https://pitchbook.com/profiles/fund/21738-79F
https://twitter.com/hayfincapital
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=54423598
https://www.privateequityinternational.com/database/#/profile?id=12740

Richard Baxter

Managing Director, Healthcare

Atin Dhawan

Investment Analyst

Timothy Flynn

Co-Founder, CEO and Member of Executive Committee

Olaf Hartmann

Portfolio Manager and Managing Director

Sheharyar Malik

Investment Analyst

Mark Tognolini

Co-Founder, COO and Member, Management Committee

Andrew Merrill

Managing Director, Healthcare

Past deals in Oregon

HeartFlow

Convertible Note in 2025
HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

HeartFlow

Series F in 2023
HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.